UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number: 001-12102
YPF Sociedad Anónima
(Exact name of registrant as specified in its charter)
Macacha Güemes 515
C1106BKK Buenos Aires, Argentina
(Address of principal executive office)
Indicate by check mark whether... (continue reading...)
Filed Pursuant to Rule 424(b)(5) Registration No. 333-297410
The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are part of an effective registration statement filed with the Securities and Exchange Commission. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and they are not soliciting... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K NOVO NORDISK A S For: Jul 13
-
Form 6-K Greenfire Resources Ltd. For: Jul 13
-
Form N-PX Popular U.S. Government For: Jun 30
-
Form 13F-HR Quintet Private Bank For: Jun 30
-
Form 8-K TACTILE SYSTEMS TECHNOLO For: Jul 13
-
Form FWP World Omni Select Auto Filed by: WORLD OMNI AUTO RECEIVABLES LLC
-
Form 13F-HR University of Cambridge For: Jun 30
-
Form 13F-HR Waterway Wealth Manageme For: Jun 30
-
Form 8-K WILLIAMS COMPANIES, INC. For: Jul 10
-
Form 4 Canadian Solar Inc. For: Jul 09 Filed by: Chang Leslie Li Hsien
-
Form 25-NSE Esperion Therapeutics, Filed by: Nasdaq Stock Market LLC
-
Form 4 Canadian Solar Inc. For: Jul 09 Filed by: Wong Pauline W.
-
Form 425 Calisa Acquisition Corp Filed by: Calisa Acquisition Corp
-
Form 8-K Calisa Acquisition Corp For: Jul 08
-
Form 13F-HR SHELTON WEALTH MANAGEMEN For: Jun 30
-
Form 424H WORLD OMNI AUTO RECEIVAB
-
Form 8-K Fermi Inc. For: Jul 10
-
Form DEFA14A Silexion Therapeutics
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D RYL Growth Partners LLC
-
Form X-17A-5 GORDON, HASKETT CAPITAL For: Mar 31
-
Form 6-K WeRide Inc. For: Jul 13
-
Form 8-K Nordicus Partners Corp For: Jul 13
-
Form 4 IPERIONX Ltd For: Jul 10 Filed by: Symonds Toby Edgcumbe
-
Form D Databricks 1 Mar 2025 a
-
Form 8-K Esperion Therapeutics, For: Jul 13
-
Form 425 GENCO SHIPPING & TRADING Filed by: DIANA SHIPPING INC.
-
Form 8-A12B Tidal Trust II
-
Form 6-K Alarum Technologies Ltd. For: Jul 13
-
Form SC TO-T/A GENCO SHIPPING & TRADING Filed by: DIANA SHIPPING INC.
-
Form 425 Huntsman CORP Filed by: OLIN Corp
-
Form D Moxies SPV Sep 2025 a
-
Form 8-K Klaviyo, Inc. For: Jul 13
-
Form 8-K Ferguson Enterprises For: Jul 13
-
Form 8-K ONCOLYTICS BIOTECH INC For: Jul 13
-
Form N-PX One Wealth Management For: Jun 30
-
Form S-3ASR HEICO CORP
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 497K Tidal Trust II
-
Form 13F-HR Olistico Wealth, LLC For: Jun 30
-
Form 8-K Dare Bioscience, Inc. For: Jul 13
-
Form 15-12G Janus Henderson Group
-
Form 15-15D Janus Henderson US (Hold
-
Form 6-K SRIVARU Holding Ltd For: Jul 13
-
Form 6-K InMode Ltd. For: Jul 13
-
Form 4 Anixa Biosciences Inc For: Jul 10 Filed by: KUMAR AMIT
-
Form N-PX HORAN Wealth, LLC For: Jun 30
-
Form 8-K SouthState Bank Corp For: Jul 09
-
Form ABS-EE WORLD OMNI AUTO RECEIVAB For: Jun 30
-
Form D GSBackers VELA Fund I a

